García-Velasco J A, González González A
Department of Obstetrics and Gynecology, La Paz Hospital, Autonoma University, Madrid, Spain.
Int J Gynaecol Obstet. 1998 Jun;61(3):239-44. doi: 10.1016/s0020-7292(98)00053-8.
To compare the tocolytic efficacy and maternal tolerance of nifedipine with ritodrine in the management of threatened preterm labor.
Prospective randomized study of 52 singleton pregnancies with preterm labor between 26 and 34 week's gestation. The capacity to delay delivery 48 h, 7 days, until week 36 or until fetal weight reached 2500 g were the outcome variables assessed. Doppler ultrasound studies were performed on the fetal umbilical artery as control.
No significant differences were found in the delay of delivery, but significantly fewer maternal side-effects were found in the nifedipine group. Doppler ultrasound results were similar in both groups.
Nifedipine is a valid and well-tolerated alternative among the tocolytic drugs, and apparently does not significantly alter fetal vascular blood flow.
比较硝苯地平与利托君在治疗先兆早产中的宫缩抑制疗效及母体耐受性。
对52例妊娠26至34周的单胎先兆早产孕妇进行前瞻性随机研究。评估延迟分娩48小时、7天、至36周或直至胎儿体重达到2500克的能力作为结局变量。以胎儿脐动脉多普勒超声检查作为对照。
在延迟分娩方面未发现显著差异,但硝苯地平组的母体副作用明显较少。两组的多普勒超声结果相似。
硝苯地平是宫缩抑制药物中一种有效的且耐受性良好的替代药物,并且显然不会显著改变胎儿血管血流。